Acadian Asset Management LLC Sonoma Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.23 - $8.89 $27,363 - $46,512	-5,232 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$7.12 - $9.15 $5,653 - $7,265	-794 Reduced 13.18%	5,232 $38,000
Q1 2021 May 11, 2021	SELL	$6.81 - $9.64 $17,208 - $24,360	-2,527 Reduced 29.55%	6,026 $45,000
Q2 2020 Aug 12, 2020	BUY	$4.72 - $9.7 $33,049 - $67,919	7,002 Added 451.45%	8,553 $61,000
Q2 2019 Aug 08, 2019	BUY	$6.39 - $8.91 $9,910 - $13,819	1,551 New	1,551 $12,000

2.27K

Ticker SNOA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,100,940
Market Cap $8.84M
Description
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.